The prevalence of ERM has been previously reported to be higher for MYO7A than other forms of RP, up to 56%.31 However, in this study, only 22% of the patients had unilateral or bilateral ERM, similar to previous reports (22–27%) by Triolo et al.48and Liew et al.49Twenty-four of our patients had CMO in at least one eye, showing a similar prevalence compared to previous reports in patients with MYO7A (27%–58%).46 This evidence concerns the gene MYO7A and retinitis pigmentosa 1.